Haverford Trust Co purchased a new position in shares of Merck KGaA (OTCMKTS:MKGAF – Free Report) in the second quarter, HoldingsChannel reports. The firm purchased 272,415 shares of the company’s stock, valued at approximately $35,005,000.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Gables Capital Management Inc. purchased a new stake in Merck KGaA in the 2nd quarter valued at about $2,095,000. Diversify Advisory Services LLC acquired a new position in Merck KGaA in the second quarter valued at about $3,810,000. Danske Bank A S purchased a new position in Merck KGaA during the second quarter worth about $276,535,000. Danica Pension Livsforsikringsaktieselskab purchased a new position in Merck KGaA during the second quarter worth about $25,541,000. Finally, BOK Financial Private Wealth Inc. acquired a new stake in shares of Merck KGaA during the second quarter valued at about $523,000. 0.10% of the stock is owned by institutional investors and hedge funds.
Merck KGaA Price Performance
Merck KGaA stock opened at $163.21 on Friday. The company’s 50 day simple moving average is $162.62 and its 200-day simple moving average is $148.46. The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.84 and a current ratio of 1.31. Merck KGaA has a 1 year low of $116.68 and a 1 year high of $175.56. The company has a market capitalization of $21.09 billion, a price-to-earnings ratio of 24.92 and a beta of 0.96.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Further Reading
- Five stocks we like better than Merck KGaA
- 2 Biotech Stocks Shaping Up for Major Breakouts
- 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs
- 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run
- Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
